Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 30;6(4):92.
doi: 10.3390/diseases6040092.

Prevention of Progression in Myopia: A Systematic Review

Aldo Vagge  1 , Lorenzo Ferro Desideri  2 , Paolo Nucci  3 , Massimiliano Serafino  4 , Giuseppe Giannaccare  5 , Carlo E Traverso  6   7
Affiliations
Review

Prevention of Progression in Myopia: A Systematic Review

Aldo Vagge et al. Diseases. .

Abstract

The prevalence of myopia has increased worldwide in recent decades and now is endemic over the entire industrial world. This increase is mainly caused by changes in lifestyle and behavior. In particular, the amount of outdoor activities and near work would display an important role in the pathogenesis of the disease. Several strategies have been reported as effective. Spectacles and contact lenses have shown only slight results in the prevention of myopia and similarly ortokerathology should not be considered as a first-line strategy, given the high risk of infectious keratitis and the relatively low compliance for the patients. Thus, to date, atropine ophthalmic drops seem to be the most effective treatment for slowing the progression of myopia, although the exact mechanism of the effect of treatment is still uncertain. In particular, low-dose atropine (0.01%) was proven to be an effective and safe treatment in the long term due to the lowest rebound effect with negligible side effects.

Keywords: ATOM; atropine; myopia; myopia prevention; orthokeratology; spectacles.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Fledelius H.C. Ophthalmic changes from age of 10 to 18 years. A longitudinal study of sequels to low birth weight. IV. Ultrasound oculometry of vitreous and axial length. Acta Ophthalmol. 1982;60:403–411. doi: 10.1111/j.1755-3768.1982.tb03031.x. - DOI - PubMed
    1. Dolgin E. The myopia boom. Nature. 2015;519:276–278. doi: 10.1038/519276a. - DOI - PubMed
    1. Delcourt C., Korobelnik J.F., Buitendijk G.H., Foster P.J., Hammond C.J., Piermarocchi S., Peto T., Jansonius N., Mirshahi A., Hogg R.E., et al. Ophthalmic epidemiology in Europe: The “European Eye Epidemiology” (E3) consortium. Eur. J. Epidemiol. 2016;31:197–210. doi: 10.1007/s10654-015-0098-2. - DOI - PubMed
    1. Holden B.A., Fricke T.R., Wilson D.A., Jong M., Naidoo K.S., Sankaridurg P., Wong T.Y., Naduvilath T.J., Resnikoff S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology. 2016;123:1036–1042. doi: 10.1016/j.ophtha.2016.01.006. - DOI - PubMed
    1. French A.N., O’Donoghue L., Morgan I.G., Saunders K.J., Mitchell P., Rose K.A. Comparison of refraction and ocular biometry in European Caucasian children living in Northern Ireland and Sydney, Australia. Investig. Ophthalmol. Vis. Sci. 2012;53:4021–4031. doi: 10.1167/iovs.12-9556. - DOI - PubMed